The IPOPI Research Grant Programme is a new initiative aimed at promoting scientific and clinical research in the field of primary immunodeficiencies. This first grant call in 2024 supported by Grifols ran between April and August, inviting applicants from all over to world to seize the opportunity to fuel innovation in the field with […]
From 16-19 October, IPOPI’s XVIII Global Patients’ Meeting (GPM) brought together 100 participants from nearly 50 countries, in Marseille, marking a record number of National Member Organisations (NMOs). Held alongside the European Society for Immunodeficiencies (ESID) and the International Nursing Group for Immunodeficiencies’ (INGID) congresses, this flagship biennial event highlighted collaboration across the primary immunodeficiency (PID) community. Programme This meeting featured insightful sessions on mental health, innovative therapies, artificial […]
At every Global Patients’ Meeting, the IPOPI community comes together to honour outstanding contributions to the primary immunodeficiency (PID) field through the PID Champion Awards. On October 17, 2024, individuals and organisations whose efforts have made a significant impact were celebrated during a sparkling award ceremony. The prestigious LeBien Award was presented to Prof Aziz […]
In 2023, IPOPI made significant strides in improving primary immunodeficiencies (PIDs) care through impactful events, campaigns, and policy efforts, all aligned with our 2021-2025 strategic plan. A major highlight was the record-breaking International Primary Immunodeficiencies Congress (IPIC) in Rotterdam, which attracted nearly 900 attendees and fostered collaboration, advancing clinical care. Throughout the year, we released […]
